Home › Trial NCT07469982
A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors
- Trial IDNCT07469982
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorShouyao Holdings (Beijing) Co. LTD
- Enrollment122
- Start date2026-03-12
- ConditionsAdvanced or Metastatic Solid Tumors With Homozygous MTAP Deletion
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.